Evidence map›Paper›PMID 34068216›Full record

ReviewCancers2021

The Gut Microbiome and Gastrointestinal Toxicities in Pelvic Radiation Therapy: A Clinical Review.

Byeongsang Oh, Thomas Eade, Gillian Lamoury, Susan Carroll, Marita Morgia, Andrew Kneebone, George Hruby, Mark Stevens, Frances Boyle, Stephen Clarke and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Byeongsang OhNorthern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
Thomas EadeNorthern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
Gillian LamouryNorthern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.ORCID 0000-0001-9290-0193
Susan CarrollNorthern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
Marita MorgiaNorthern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
Andrew KneeboneNorthern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
George HrubyNorthern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
Mark StevensNorthern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.ORCID 0000-0001-6009-3470
Frances BoyleThe Mater Hospital, Sydney, NSW 2060, Australia.
Stephen ClarkeNorthern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
Brian CorlessNorthern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
Mark MolloyBowel Cancer and Biomarker Laboratory, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2065, Australia.ORCID 0000-0003-4679-5868
David RosenthalHarvard Medical School, Boston, MA 02215, USA.
Michael BackNorthern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
The University of Sydney · AUMater Health Services · AUHarvard University · USRoyal North Shore Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastrointestinal (GI) toxicities are common adverse effects of pelvic radiotherapy (RT). Several recent studies revealed that toxicity of RT is associated with dysbiosis of the gut microbiome.

methodA literature search was conducted in electronic databases Medline, PubMed, and ScienceDirect, with search terms "microbiome and/or microbiota" and "radiotherapy (RT) and/or chemoradiation therapy (CRT)" and "cancer", and the relevant literature were selected for use in this article.

resultsEight prospective cohort studies were selected for review with a total of 311 participants with a range of 15-134 participants within these studies. The selected studies were conducted in patients with gynaecological (

conclusionGut microbiome profiles are associated with GI toxicities and have the potential to predict RT/CRT-induced toxicities and quality of life (QoL) in patients undergoing those treatments. Further robust randomized controlled trials (RCTs) are required to elucidate the effect of gut microbiome profiles on RT-related adverse effects and responses to RT.

Indexed as

cancerchemoradiotherapygastrointestinal toxicitiesgut microbiomeradiotherapy

Identifiers

PMID34068216
PMCPMC8153110
OpenAlexW3163249212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.